Simultaneous determination of evodiamine and its four metabolites in rat plasma by LC–MS/MS and its application to a pharmacokinetic study

A simple and sensitive liquid chromatography tandem mass spectrometry method was validated for simultaneous quantification of evodiamine and its metabolites 10‐hydroxyevodiamine (M1), 18‐hydroxyevodiamine (M2), 10‐hydroxyevodiamine‐glucuronide (M3) and 18‐hydroxy‐ evodiamine‐glucuronide (M4) in rat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biomedical chromatography 2018-07, Vol.32 (7), p.e4219-n/a
Hauptverfasser: Wang, Cuiyun, Yue, Fang, Ai, Guangfeng, Yang, Jie
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page n/a
container_issue 7
container_start_page e4219
container_title Biomedical chromatography
container_volume 32
creator Wang, Cuiyun
Yue, Fang
Ai, Guangfeng
Yang, Jie
description A simple and sensitive liquid chromatography tandem mass spectrometry method was validated for simultaneous quantification of evodiamine and its metabolites 10‐hydroxyevodiamine (M1), 18‐hydroxyevodiamine (M2), 10‐hydroxyevodiamine‐glucuronide (M3) and 18‐hydroxy‐ evodiamine‐glucuronide (M4) in rat plasma for the first time. The analytes were extracted with acetonitrile and separated on a C18 column within 3 min. The detection was achieved in positive selected reaction monitoring mode with precursor‐to‐product transitions at m/z 304.1 → 161.1 for evodiamine, m/z 320.1 → 134.1 for M1, m/z 320.1 → 150.1 for M2, m/z 496.2 → 134.1 for M3, m/z 496.2 → 171.1 for M4 and m/z 349.2 → 305.1 for camptothecin (internal standard). The linearity was evident over the tested concentration ranges with correlation coefficients >0.9991. The lower limits of quantification for evodiamine, M1, M2, M3 and M4 were 0.1, 0.1, 0.1, 0.25 and 0.25 ng mL−1, respectively. Extraction recoveries and matrix effects of the analytes were within the ranges of 84.51–97.21 and 90.13–103.30%, respectively. The accuracy (relative error) ranged from −8.14 to 7.23% while the intra‐ and inter‐day precisions (relative standard deviation) were 
doi_str_mv 10.1002/bmc.4219
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2007984059</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2007984059</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3219-f3d591c3b26f857f702c30e9bf927481a26640d03900d4ccc1879dd11bec6ac93</originalsourceid><addsrcrecordid>eNp1kL1OwzAQgC0EoqUg8QTII0vas5Mm8QgVf1IrhsIcObYjDHEcbAfUjQdg4w15ElIKFQvTSafvPuk-hI4JjAkAnZRGjBNK2A4aEmAsghzILhoCTVkU5xkboAPvHwGApTTbRwPKkgzyJB-i96U2XR14o2znsVRBOaMbHrRtsK2werFS836jMG8k1sHjynYOGxV4aWsdlMe6wY4H3NbcG47LFZ7PPt8-FsvJYrk94m1ba7HRBos5bh-4M1zYp14dtMA-dHJ1iPYqXnt19DNH6P7y4m52Hc1vr25mZ_NIxP2TURXLKSMiLmla5dOsyoCKGBQrK0azJCecpmkCEmIGIBMhBOkTSElIqUTKBYtH6HTjbZ197pQPhdFeqLreZCgoQMbyBKZ_UOGs905VReu04W5VECjW7Yu-fbFu36MnP9auNEpuwd_YPRBtgFddq9W_ouJ8MfsWfgHZsI_h</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2007984059</pqid></control><display><type>article</type><title>Simultaneous determination of evodiamine and its four metabolites in rat plasma by LC–MS/MS and its application to a pharmacokinetic study</title><source>Access via Wiley Online Library</source><creator>Wang, Cuiyun ; Yue, Fang ; Ai, Guangfeng ; Yang, Jie</creator><creatorcontrib>Wang, Cuiyun ; Yue, Fang ; Ai, Guangfeng ; Yang, Jie</creatorcontrib><description>A simple and sensitive liquid chromatography tandem mass spectrometry method was validated for simultaneous quantification of evodiamine and its metabolites 10‐hydroxyevodiamine (M1), 18‐hydroxyevodiamine (M2), 10‐hydroxyevodiamine‐glucuronide (M3) and 18‐hydroxy‐ evodiamine‐glucuronide (M4) in rat plasma for the first time. The analytes were extracted with acetonitrile and separated on a C18 column within 3 min. The detection was achieved in positive selected reaction monitoring mode with precursor‐to‐product transitions at m/z 304.1 → 161.1 for evodiamine, m/z 320.1 → 134.1 for M1, m/z 320.1 → 150.1 for M2, m/z 496.2 → 134.1 for M3, m/z 496.2 → 171.1 for M4 and m/z 349.2 → 305.1 for camptothecin (internal standard). The linearity was evident over the tested concentration ranges with correlation coefficients &gt;0.9991. The lower limits of quantification for evodiamine, M1, M2, M3 and M4 were 0.1, 0.1, 0.1, 0.25 and 0.25 ng mL−1, respectively. Extraction recoveries and matrix effects of the analytes were within the ranges of 84.51–97.21 and 90.13–103.30%, respectively. The accuracy (relative error) ranged from −8.14 to 7.23% while the intra‐ and inter‐day precisions (relative standard deviation) were &lt; 9.31%. The validated assay was successfully applied for the pharmacokinetic study of evodiamine, M1, M2, M3 and M4 in rat. The current study will be helpful in understanding the in vivo disposition of evodiamine.</description><identifier>ISSN: 0269-3879</identifier><identifier>EISSN: 1099-0801</identifier><identifier>DOI: 10.1002/bmc.4219</identifier><identifier>PMID: 29470848</identifier><language>eng</language><publisher>England</publisher><subject>evodiamine ; LC–MS/MS ; metabolite ; pharmacokinetics</subject><ispartof>Biomedical chromatography, 2018-07, Vol.32 (7), p.e4219-n/a</ispartof><rights>Copyright © 2018 John Wiley &amp; Sons, Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3219-f3d591c3b26f857f702c30e9bf927481a26640d03900d4ccc1879dd11bec6ac93</citedby><cites>FETCH-LOGICAL-c3219-f3d591c3b26f857f702c30e9bf927481a26640d03900d4ccc1879dd11bec6ac93</cites><orcidid>0000-0003-4013-5367</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fbmc.4219$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fbmc.4219$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29470848$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wang, Cuiyun</creatorcontrib><creatorcontrib>Yue, Fang</creatorcontrib><creatorcontrib>Ai, Guangfeng</creatorcontrib><creatorcontrib>Yang, Jie</creatorcontrib><title>Simultaneous determination of evodiamine and its four metabolites in rat plasma by LC–MS/MS and its application to a pharmacokinetic study</title><title>Biomedical chromatography</title><addtitle>Biomed Chromatogr</addtitle><description>A simple and sensitive liquid chromatography tandem mass spectrometry method was validated for simultaneous quantification of evodiamine and its metabolites 10‐hydroxyevodiamine (M1), 18‐hydroxyevodiamine (M2), 10‐hydroxyevodiamine‐glucuronide (M3) and 18‐hydroxy‐ evodiamine‐glucuronide (M4) in rat plasma for the first time. The analytes were extracted with acetonitrile and separated on a C18 column within 3 min. The detection was achieved in positive selected reaction monitoring mode with precursor‐to‐product transitions at m/z 304.1 → 161.1 for evodiamine, m/z 320.1 → 134.1 for M1, m/z 320.1 → 150.1 for M2, m/z 496.2 → 134.1 for M3, m/z 496.2 → 171.1 for M4 and m/z 349.2 → 305.1 for camptothecin (internal standard). The linearity was evident over the tested concentration ranges with correlation coefficients &gt;0.9991. The lower limits of quantification for evodiamine, M1, M2, M3 and M4 were 0.1, 0.1, 0.1, 0.25 and 0.25 ng mL−1, respectively. Extraction recoveries and matrix effects of the analytes were within the ranges of 84.51–97.21 and 90.13–103.30%, respectively. The accuracy (relative error) ranged from −8.14 to 7.23% while the intra‐ and inter‐day precisions (relative standard deviation) were &lt; 9.31%. The validated assay was successfully applied for the pharmacokinetic study of evodiamine, M1, M2, M3 and M4 in rat. The current study will be helpful in understanding the in vivo disposition of evodiamine.</description><subject>evodiamine</subject><subject>LC–MS/MS</subject><subject>metabolite</subject><subject>pharmacokinetics</subject><issn>0269-3879</issn><issn>1099-0801</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp1kL1OwzAQgC0EoqUg8QTII0vas5Mm8QgVf1IrhsIcObYjDHEcbAfUjQdg4w15ElIKFQvTSafvPuk-hI4JjAkAnZRGjBNK2A4aEmAsghzILhoCTVkU5xkboAPvHwGApTTbRwPKkgzyJB-i96U2XR14o2znsVRBOaMbHrRtsK2werFS836jMG8k1sHjynYOGxV4aWsdlMe6wY4H3NbcG47LFZ7PPt8-FsvJYrk94m1ba7HRBos5bh-4M1zYp14dtMA-dHJ1iPYqXnt19DNH6P7y4m52Hc1vr25mZ_NIxP2TURXLKSMiLmla5dOsyoCKGBQrK0azJCecpmkCEmIGIBMhBOkTSElIqUTKBYtH6HTjbZ197pQPhdFeqLreZCgoQMbyBKZ_UOGs905VReu04W5VECjW7Yu-fbFu36MnP9auNEpuwd_YPRBtgFddq9W_ouJ8MfsWfgHZsI_h</recordid><startdate>201807</startdate><enddate>201807</enddate><creator>Wang, Cuiyun</creator><creator>Yue, Fang</creator><creator>Ai, Guangfeng</creator><creator>Yang, Jie</creator><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-4013-5367</orcidid></search><sort><creationdate>201807</creationdate><title>Simultaneous determination of evodiamine and its four metabolites in rat plasma by LC–MS/MS and its application to a pharmacokinetic study</title><author>Wang, Cuiyun ; Yue, Fang ; Ai, Guangfeng ; Yang, Jie</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3219-f3d591c3b26f857f702c30e9bf927481a26640d03900d4ccc1879dd11bec6ac93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>evodiamine</topic><topic>LC–MS/MS</topic><topic>metabolite</topic><topic>pharmacokinetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wang, Cuiyun</creatorcontrib><creatorcontrib>Yue, Fang</creatorcontrib><creatorcontrib>Ai, Guangfeng</creatorcontrib><creatorcontrib>Yang, Jie</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Biomedical chromatography</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wang, Cuiyun</au><au>Yue, Fang</au><au>Ai, Guangfeng</au><au>Yang, Jie</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Simultaneous determination of evodiamine and its four metabolites in rat plasma by LC–MS/MS and its application to a pharmacokinetic study</atitle><jtitle>Biomedical chromatography</jtitle><addtitle>Biomed Chromatogr</addtitle><date>2018-07</date><risdate>2018</risdate><volume>32</volume><issue>7</issue><spage>e4219</spage><epage>n/a</epage><pages>e4219-n/a</pages><issn>0269-3879</issn><eissn>1099-0801</eissn><abstract>A simple and sensitive liquid chromatography tandem mass spectrometry method was validated for simultaneous quantification of evodiamine and its metabolites 10‐hydroxyevodiamine (M1), 18‐hydroxyevodiamine (M2), 10‐hydroxyevodiamine‐glucuronide (M3) and 18‐hydroxy‐ evodiamine‐glucuronide (M4) in rat plasma for the first time. The analytes were extracted with acetonitrile and separated on a C18 column within 3 min. The detection was achieved in positive selected reaction monitoring mode with precursor‐to‐product transitions at m/z 304.1 → 161.1 for evodiamine, m/z 320.1 → 134.1 for M1, m/z 320.1 → 150.1 for M2, m/z 496.2 → 134.1 for M3, m/z 496.2 → 171.1 for M4 and m/z 349.2 → 305.1 for camptothecin (internal standard). The linearity was evident over the tested concentration ranges with correlation coefficients &gt;0.9991. The lower limits of quantification for evodiamine, M1, M2, M3 and M4 were 0.1, 0.1, 0.1, 0.25 and 0.25 ng mL−1, respectively. Extraction recoveries and matrix effects of the analytes were within the ranges of 84.51–97.21 and 90.13–103.30%, respectively. The accuracy (relative error) ranged from −8.14 to 7.23% while the intra‐ and inter‐day precisions (relative standard deviation) were &lt; 9.31%. The validated assay was successfully applied for the pharmacokinetic study of evodiamine, M1, M2, M3 and M4 in rat. The current study will be helpful in understanding the in vivo disposition of evodiamine.</abstract><cop>England</cop><pmid>29470848</pmid><doi>10.1002/bmc.4219</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0003-4013-5367</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0269-3879
ispartof Biomedical chromatography, 2018-07, Vol.32 (7), p.e4219-n/a
issn 0269-3879
1099-0801
language eng
recordid cdi_proquest_miscellaneous_2007984059
source Access via Wiley Online Library
subjects evodiamine
LC–MS/MS
metabolite
pharmacokinetics
title Simultaneous determination of evodiamine and its four metabolites in rat plasma by LC–MS/MS and its application to a pharmacokinetic study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T10%3A16%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Simultaneous%20determination%20of%20evodiamine%20and%20its%20four%20metabolites%20in%20rat%20plasma%20by%20LC%E2%80%93MS/MS%20and%20its%20application%20to%20a%20pharmacokinetic%20study&rft.jtitle=Biomedical%20chromatography&rft.au=Wang,%20Cuiyun&rft.date=2018-07&rft.volume=32&rft.issue=7&rft.spage=e4219&rft.epage=n/a&rft.pages=e4219-n/a&rft.issn=0269-3879&rft.eissn=1099-0801&rft_id=info:doi/10.1002/bmc.4219&rft_dat=%3Cproquest_cross%3E2007984059%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2007984059&rft_id=info:pmid/29470848&rfr_iscdi=true